Sakura, Japan

Shigenori Nakanishi


Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 28(Granted Patents)


Location History:

  • Chiba, JP (1985 - 1989)
  • Sakura, JP (1991 - 2001)

Company Filing History:


Years Active: 1985-2001

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Shigenori Nakanishi: Innovating Anti-Allergic Agents in Sakura, Japan

Introduction

Shigenori Nakanishi is a prominent inventor located in Sakura, Japan, known for his contributions to the field of medicinal chemistry. With a total of seven patents to his name, Nakanishi has made significant strides in developing innovative anti-allergic agents derived from quinolinone glycosides.

Latest Patents

Nakanishi's latest patents focus on the synthesis and applications of quinolinone glycosides. One of his key inventions is a novel quinolinone glycoside aimed at serving as a medicine. This patent outlines a comprehensive production process along with the intermediates necessary for synthesizing these compounds. The ultimate goal is to provide effective anti-allergic agents that utilize the quinolinone glycoside as an active ingredient. His work also includes the development of 7-aminoquinolinone derivatives and their physiologically acceptable salts, further enhancing the potential for these compounds in therapeutic applications.

Career Highlights

At Dainippon Ink and Chemicals, Incorporated, Nakanishi collaborates with a dedicated team of researchers. His innovative mindset has led to the creation of several impactful patents, reinforcing his reputation in the pharmaceutical industry. The focus of his research has consistently been directed toward finding viable solutions to allergic reactions through chemical innovations.

Collaborations

Throughout his career, Nakanishi has worked alongside notable colleagues such as Hidetsugu Takagaki and Masayoshi Abe. Their collaborative efforts have been integral to driving forward the research on quinolinone derivatives and enhancing the therapeutic applications of these compounds.

Conclusion

Shigenori Nakanishi's contributions to the development of anti-allergic agents through his patented inventions hold significant promise for the medical field. His ongoing work at Dainippon Ink and Chemicals, Incorporated, alongside his colleagues, emphasizes his commitment to advancing pharmaceutical innovations that aim to improve the quality of life for individuals suffering from allergies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…